Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 0.23 is 153% above its 5-year average of -0.44, near the high end of its 5-year range (-1.10–0.28).
156.10% above its 12-month average of -0.41.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.04.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T21:47:44.765Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
0.23
EARNINGS PER SHARE (EPS) AVG TTM
-0.41
EARNINGS PER SHARE (EPS) AVG 3Y
-0.62
EARNINGS PER SHARE (EPS) AVG 5Y
-0.44
EARNINGS PER SHARE (EPS) AVG 10Y
-0.30
EARNINGS PER SHARE (EPS) AVG 15Y
-0.22
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+156.10%
CURRENT VS 3Y AVG
+136.95%
CURRENT VS 5Y AVG
+152.71%
CURRENT VS 10Y AVG
+177.35%
CURRENT VS 15Y AVG
+202.45%
CURRENT VS 20Y AVG
N/A
OptimizeRx Corp.
Market Cap
$165.32M
Earnings Per Share (EPS)
0.23
TTM Avg
-0.41
3Y Avg
-0.62
5Y Avg
-0.44
Market Cap
$165.27M
Earnings Per Share (EPS)
-1.57
TTM Avg
-1.50
3Y Avg
-2.00
5Y Avg
-2.13
Market Cap
$168.10M
Earnings Per Share (EPS)
-27.00
TTM Avg
-15.00
3Y Avg
-27.00
5Y Avg
-32.85
Market Cap
$162.04M
Earnings Per Share (EPS)
-2.63
TTM Avg
-1.75
3Y Avg
-1.74
5Y Avg
-1.61
Market Cap
$168.92M
Earnings Per Share (EPS)
-1.60
TTM Avg
-2.56
3Y Avg
-2.45
5Y Avg
-2.61
Market Cap
$169.53M
Earnings Per Share (EPS)
-0.23
TTM Avg
-0.59
3Y Avg
-0.77
5Y Avg
-0.88
Market Cap
$159.80M
Earnings Per Share (EPS)
-28.87
TTM Avg
-17.24
3Y Avg
-11.28
5Y Avg
-9.01
Market Cap
$159.78M
Earnings Per Share (EPS)
-1.50
TTM Avg
-2.49
3Y Avg
-3.17
5Y Avg
-2.41
Market Cap
$171.13M
Earnings Per Share (EPS)
-2.80
TTM Avg
-1.25
3Y Avg
-14.14
5Y Avg
-22.50
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OptimizeRx Corp. (OPRX) | $165.32M | 0.23 | -0.41 | -0.62 | -0.44 |
| Nkarta, Inc. (NKTX)vs › | $165.27M | -1.57 | -1.50 | -2.00 | -2.13 |
| Cue Biopharma, Inc. (CUE)vs › | $168.10M | -27.00 | -15.00 | -27.00 | -32.85 |
| Quanterix Corporation (QTRX)vs › | $162.04M | -2.63 | -1.75 | -1.74 | -1.61 |
| MediWound Ltd. (MDWD)vs › | $168.92M | -1.60 | -2.56 | -2.45 | -2.61 |
| Journey Medical Corporation (DERM)vs › | $169.53M | -0.23 | -0.59 | -0.77 | -0.88 |
| Minerva Neurosciences, Inc. (NERV)vs › | $159.80M | -28.87 | -17.24 | -11.28 | -9.01 |
| PepGen Inc. (PEPG)vs › | $159.78M | -1.50 | -2.49 | -3.17 | -2.41 |
| Precision BioSciences, Inc. (DTIL)vs › | $171.13M | -2.80 | -1.25 | -14.14 | -22.50 |
| LifeMD, Inc. (LFMDP)vs › | $159.22M | -0.51 | -0.38 | -0.76 | -1.59 |
Trailing EPS (TTM)
$0.23
Forward EPS (Est.)
$0.90
P/E Ratio
37.7
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 0.28 |
| 2024-12-31 | -1.10 |
| 2023-12-31 | -1.03 |
| 2022-12-31 | -0.64 |
| 2021-12-31 | 0.02 |
| 2020-12-31 | -0.15 |
| 2019-12-31 | -0.23 |
| 2018-12-31 | 0.02 |
| 2017-12-31 | -0.21 |
| 2016-12-31 | -0.16 |
| 2015-12-31 | -0.07 |
| 2014-12-31 | -0.14 |
| 2013-12-31 | -0.06 |
| 2012-12-31 | -0.08 |
| 2011-12-31 | -0.46 |
| 2010-12-31 | -0.46 |
| 2009-12-31 | -1.09 |
| 2008-12-31 | -1.06 |
| 2007-12-31 | -0.10 |
